• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Bard wins 3DMax hernia mesh appeal

Bard wins 3DMax hernia mesh appeal

March 20, 2018 By Fink Densford

The New Jersey Superior Court’s Appellate Division this week tossed a win to Becton Dickinson & Co.‘s (NYSE:BDX) C.R. Bard (NYSE:BCR), refusing to reinstate a hernia mesh product liability suit on grounds that expert witnesses couldn’t prove the design of the product was defective or that significant negligence occurred.

In the case, plaintiff Kemuel Goodson claims that implantation of Bard’s 3DMax polypropylene mesh during a laparoscopic bilateral inguinal hernia repair in 2006 caused a number of different complications, including remaining pain and the removal of a testicle, and required a number of future procedures.

In his original suit, the plaintiff asserted claims of defective design, negligence and fraud and misrepresentation.

Bard moved for a summary judgement, which was granted, and the plaintiff appealed, claiming the court “erred in granting summary judgement to the defendant on the plaintiff’s claims of design defect and negligence,” according to court documents.

After review, expert testimony from the plaintiffs three expert witnesses was not found to meet the requirements for claims of defectiveness, the three-judge appellate panel decided.

“In the instant case, none of the experts specifically opined that 3DMax is defective and that this defective design caused the medical complications complained of by the plaintiff. Instead, plaintiff’s three experts gave general opinions about the various medical risks of the product that can cause complications. This is not enough to overcome the summary judgement standard,” the three-judge appellate panel wrote. “In addition, no expert presented an alternative, feasible design for the 3DMax. As previously stated, this is one of the determining factors in a defective design case.”

The dismissal of the negligence claims were also affirmed, with the court saying that to establish such a claim, the plaintiff must show that the “defendant had a duty to warn, that the defendant breached that duty, and that the preach proximately caused the plaintiff’s injury,” according to court documents.

The operating surgeon previously testified that while he wasn’t specifically informed of some complications associated with the hernia mesh, he was aware of those possible side effects as associated with meshes in general, including those experienced by the plaintiff.

“Notwithstanding, Dr. Middleton testified he went over the risks of the mesh surgery with plaintiff prior to the surgery, including the risk of chronic pain, numbness, hematoma, and mesh infection,” the panel wrote. “As plaintiff’s physician, Dr. Middleton was serving in the role of a learned intermediary. Despite the doctor’s decision to not read the manufacturer’s warnings, that decision does not alter his learned intermediary role nor does it impose liability on defendants for failure to warn.”

Filed Under: Legal News, Surgical Tagged With: becton dickinson, C.R. Bard

More recent news

  • Endologix is now Rhevera Medical
  • iRhythm completes acquisition of VitalConnect
  • Medtronic taps Siemens Healthineers exec as new Cardiac Ablations Solutions VP
  • Stryker will have a new CEO next year
  • Zenflow nets $52M, Cook Medical deal for in-office enlarged prostate implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy